Showing results (21-30 of 53) with videos related to

Sort By:
Pageof 6
Discovery Medicine|January 1, 2015
Immune checkpoint blockade as a novel immunotherapeutic strategy for renal cell carcinoma: a review of clinical trialsJ Luke Godwin, Matthew Zibelman, Elizabeth R Plimack, et al.
Clinical Advances in Hematology & Oncology : H&O|April 11, 2019
Update on perioperative systemic therapy for urothelial carcinomaKeren Rouvinov, Elizabeth R Plimack, Matthew Zibelman, et al.
Urology Case Reports|December 20, 2019
Neoadjuvant checkpoint inhibition in renal cell carcinoma associated Stauffer's syndromeKevin Zarrabi, Selma Masic, Christopher Schaefer, et al.
Kidney Cancer (Clifton, Va.)|October 19, 2018
The Evolution of Clinical Trials in Renal Cell Carcinoma: A Status Report for 2013-2016 from the ClinicalTrials.gov WebsitePooja Ghatalia, Rebecca Koenigsberg, David Pisarcik, et al.
Clinical Genitourinary Cancer|March 28, 2026
Assessing Treatment Outcomes of Patients Undergoing Enfortumab Vedotin Dose Reduction in Metastatic Bladder CancerHal Rives, Jordan Fredette, Fern Anari, et al.
Molecular Cancer Therapeutics|March 30, 2020
An Emerging Landscape for Canonical and Actionable Molecular Alterations in Primary and Metastatic Prostate CancerNancy A Dawson, Matthew Zibelman, Timothy Lindsay, et al.
Clinical Genitourinary Cancer|October 10, 2024
Survival Outcomes in Patients With Muscle-Invasive Bladder Cancer Receiving Neoadjuvant Chemotherapy Stratified by Number of CyclesAnumita Chakraborty, Jill Hasler, Elizabeth Handorf, et al.
European Urology|June 9, 2018
Treatment Facility Volume and Survival in Patients with Metastatic Renal Cell Carcinoma: A Registry-based AnalysisShreyas S Joshi, Elizabeth A Handorf, Matthew Zibelman, et al.
Pageof 6